Background: Thromboprophylaxis in bariatric surgery is widely debated; however, few large articles evaluate treatment plans and their efficacy. Herein, we make the first large-scale report of the safety and efficacy of apixaban (Eliquis) for thrombus prevention following bariatric surgery.
Purpose: To evaluate the safety and efficacy of apixaban following bariatric surgery.
Background: There are no comparative studies on the long-term outcomes after the primary traditional duodenal switch (DS) and single-anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S).
Purpose: This study aims to compare the long-term outcomes in a matched cohort.
Setting: This study took place in a single private institute, in the USA.
Background: The long-term effectiveness of Roux-en-Y gastric bypass (RYGB) and single-anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S) is unknown.
Purpose: Compare the long-term outcomes.
Setting: Single private institute, USA.
Background: The long-term outcomes of primary single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) have never been reported in the literature.
Objectives: The study aimed to evaluate the long-term outcomes after primary laparoscopic SADI-S (LSADI-S).
Setting: Single, private institute, United States.
Introduction: Recently, a single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) has become increasingly popular for patients with BMI > 50 as a primary or staged surgery. Staging allows surgeons to do the sleeve gastrectomy (SG) first with the conversion only happening when a failure or technical challenge is identified.
Purpose: We present the mid-term outcomes of SADI bypass surgery after SG.